Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Passage Bio Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
PASG
Nasdaq
8731
https://www.passagebio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Passage Bio Inc
Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
- Apr 22nd, 2024 11:00 am
Passage Bio, Inc. (PASG) Is Up 24.26% in One Week: What You Should Know
- Mar 7th, 2024 5:00 pm
Passage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship Program
- Mar 5th, 2024 12:00 pm
Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights
- Mar 4th, 2024 12:00 pm
Passage Bio to Participate in Upcoming Investor Conferences
- Feb 27th, 2024 12:00 pm
We Think Passage Bio (NASDAQ:PASG) Needs To Drive Business Growth Carefully
- Feb 12th, 2024 2:14 pm
7 Analyst-Backed Stocks With Promising 10-Bagger Potential
- Feb 2nd, 2024 12:09 am
Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
- Jan 31st, 2024 12:30 pm
7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight
- Dec 26th, 2023 3:14 am
Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities
- Dec 20th, 2023 12:00 pm
Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
- Nov 17th, 2023 9:30 pm
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
- Nov 13th, 2023 12:00 pm
Passage Bio to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conference
- Oct 30th, 2023 11:00 am
Passage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Oct 20th, 2023 8:30 pm
Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines Conference
- Sep 25th, 2023 11:00 am
Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?
- Sep 5th, 2023 1:31 pm
Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights
- Aug 7th, 2023 11:15 am
Passage Bio Announces Promising Interim Clinical Data from First Eight Patients with GM1 Gangliosidosis in Imagine-1 Study
- Aug 7th, 2023 11:00 am
Passage Bio Welcomes Dolan Sondhi, Ph.D. to Board Of Directors
- Jul 31st, 2023 11:00 am
12 Best Nano Cap Stocks To Buy Now
- Jul 6th, 2023 3:17 pm
Scroll